181 related articles for article (PubMed ID: 7783538)
21. Viridans-group streptococcal infections in immunocompromised hosts.
Shenep JL
Int J Antimicrob Agents; 2000 Mar; 14(2):129-35. PubMed ID: 10720803
[TBL] [Abstract][Full Text] [Related]
22. Viridans group streptococci in febrile neutropenic cancer patients: what should we fear?
Freifeld AG; Razonable RR
Clin Infect Dis; 2014 Jul; 59(2):231-3. PubMed ID: 24755859
[No Abstract] [Full Text] [Related]
23. Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors.
Bochud PY; Eggiman P; Calandra T; Van Melle G; Saghafi L; Francioli P
Clin Infect Dis; 1994 Jan; 18(1):25-31. PubMed ID: 8054434
[TBL] [Abstract][Full Text] [Related]
24. High-dose cytosine arabinoside and viridans streptococcus sepsis in children with leukemia.
Rossetti F; Cesaro S; Putti MC; Zanesco L
Pediatr Hematol Oncol; 1995; 12(4):387-92. PubMed ID: 7577391
[TBL] [Abstract][Full Text] [Related]
25. Three cases of viridans group streptococcal bacteremia in children with febrile neutropenia and literature review.
Danilatou V; Mantadakis E; Galanakis E; Christidou A; Stiakaki E; Kalmanti M
Scand J Infect Dis; 2003; 35(11-12):873-6. PubMed ID: 14723365
[TBL] [Abstract][Full Text] [Related]
26. Serious complications of bacteremia caused by Viridans streptococci in neutropenic patients with cancer.
Marron A; Carratalà J; González-Barca E; Fernández-Sevilla A; Alcaide F; Gudiol F
Clin Infect Dis; 2000 Nov; 31(5):1126-30. PubMed ID: 11073739
[TBL] [Abstract][Full Text] [Related]
27. High frequency of streptococcal bacteraemia during childhood AML therapy irrespective of dose of cytarabine.
Johannsen KH; Handrup MM; Lausen B; Schrøder H; Hasle H
Pediatr Blood Cancer; 2013 Jul; 60(7):1154-60. PubMed ID: 23281248
[TBL] [Abstract][Full Text] [Related]
28. Seven-year review of bacteremia caused by Streptococcus milleri and other viridans streptococci.
Salavert M; Gómez L; Rodriguez-Carballeira M; Xercavins M; Freixas N; Garau J
Eur J Clin Microbiol Infect Dis; 1996 May; 15(5):365-71. PubMed ID: 8793393
[TBL] [Abstract][Full Text] [Related]
29. Species-level assessment of the molecular basis of fluoroquinolone resistance among viridans group streptococci causing bacteraemia in cancer patients.
Sahasrabhojane P; Galloway-Peña J; Velazquez L; Saldaña M; Horstmann N; Tarrand J; Shelburne SA
Int J Antimicrob Agents; 2014 Jun; 43(6):558-62. PubMed ID: 24721231
[TBL] [Abstract][Full Text] [Related]
30. Bacteremia due to viridans streptococci that are highly resistant to penicillin: increase among neutropenic patients with cancer.
Carratalá J; Alcaide F; Fernández-Sevilla A; Corbella X; Lińares J; Gudiol F
Clin Infect Dis; 1995 May; 20(5):1169-73. PubMed ID: 7619995
[TBL] [Abstract][Full Text] [Related]
31. Streptococcal bacteremia in neutropenic adult patients.
Devaux Y; Archimbaud E; Guyotat D; Plotton C; Maupas J; Fleurette J; Fiere D
Nouv Rev Fr Hematol (1978); 1992; 34(2):191-5. PubMed ID: 1502026
[TBL] [Abstract][Full Text] [Related]
32. Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors.
Elting LS; Bodey GP; Keefe BH
Clin Infect Dis; 1992 Jun; 14(6):1201-7. PubMed ID: 1623076
[TBL] [Abstract][Full Text] [Related]
33. Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics.
Presterl E; Grisold AJ; Reichmann S; Hirschl AM; Georgopoulos A; Graninger W
J Antimicrob Chemother; 2005 Jan; 55(1):45-50. PubMed ID: 15563519
[TBL] [Abstract][Full Text] [Related]
34. Aetiology, cost of antimicrobial therapy and outcome in neutropenic patients who developed bacteraemia during antimicrobial prophylaxis: a case-control study.
Krupova Y; Novotny J; Sabo A; Mateicka F; Krcmery V
Int J Antimicrob Agents; 1998 Nov; 10(4):313-6. PubMed ID: 9916907
[TBL] [Abstract][Full Text] [Related]
35. Activity of quinolones against viridans group streptococci isolated from blood cultures of patients with haematological malignancy.
Kerr KG; Armitage HT; McWhinney PH
Support Care Cancer; 1999 Jan; 7(1):28-30. PubMed ID: 9926971
[TBL] [Abstract][Full Text] [Related]
36. Bacteraemia in neutropenic patients.
O'Connell B; Daly PA; McCann SR; Keane CT
Ir Med J; 1993; 86(6):203-5. PubMed ID: 8106229
[TBL] [Abstract][Full Text] [Related]
37. Streptococcus salivarius bacteremia and meningitis following upper gastrointestinal endoscopy and cauterization for gastric bleeding.
Carley NH
Clin Infect Dis; 1992 Apr; 14(4):947-8. PubMed ID: 1576292
[TBL] [Abstract][Full Text] [Related]
38. Clinical characteristics and antibiotic susceptibility of viridans streptococcal bacteremia in children with febrile neutropenia.
Han SB; Bae EY; Lee JW; Lee DG; Chung NG; Jeong DC; Cho B; Kang JH; Kim HK
Infection; 2013 Oct; 41(5):917-24. PubMed ID: 23640200
[TBL] [Abstract][Full Text] [Related]
39. Prevention of peritransplantation viridans streptococcal bacteremia with early vancomycin administration: a single-center observational cohort study.
Jaffe D; Jakubowski A; Sepkowitz K; Sebti R; Kiehn TE; Pamer E; Papanicolaou GA
Clin Infect Dis; 2004 Dec; 39(11):1625-32. PubMed ID: 15578362
[TBL] [Abstract][Full Text] [Related]
40. Identity of streptococcal blood isolates and oral isolates from two patients with infective endocarditis.
Fiehn NE; Gutschik E; Larsen T; Bangsborg JM
J Clin Microbiol; 1995 May; 33(5):1399-401. PubMed ID: 7615767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
